These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9566050)

  • 21. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
    Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
    Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophosphamide versus ifosfamide: to use ifosfamide or not to use, that is the three-dimensional question.
    Williams ML; Wainer IW
    Curr Pharm Des; 1999 Aug; 5(8):665-72. PubMed ID: 10469897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma.
    McNiel NO; Morgan LR
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):490-3. PubMed ID: 7298241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol.
    García Quetglas E; Azanza JR; Cardenas E; Sádaba B; Campanero MA
    Biopharm Drug Dispos; 2007 Jan; 28(1):19-33. PubMed ID: 17061296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic evaluation of norendimide in rats.
    Koch HP; Pischek G; Czejka M; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1982; 4(8):581-5. PubMed ID: 7169846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study.
    Brain EG; Rezai K; Weill S; Gauzan MF; Santoni J; Besse B; Goupil A; Turpin F; Urien S; Lokiec F
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):375-81. PubMed ID: 17106751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enantioselective disposition of R-(-)- and S-(+)-prenylamine in the rat.
    Gietl Y; Spahn H; Mutschler E
    Arzneimittelforschung; 1989 Aug; 39(8):853-6. PubMed ID: 2818674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly-isoprenylated ifosfamide analogs: Preactivated antitumor agents as free formulation or nanoassemblies.
    Skarbek C; Delahousse J; Pioche-Durieu C; Baconnais S; Deroussent A; Renevret P; Rivard M; Desmaele D; Martens T; Le Cam E; Couvreur P; Paci A
    Int J Pharm; 2017 Nov; 532(2):748-756. PubMed ID: 28546071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.
    Kerbusch T; de Kraker J; Keizer HJ; van Putten JW; Groen HJ; Jansen RL; Schellens JH; Beijnen JH
    Clin Pharmacokinet; 2001 Jan; 40(1):41-62. PubMed ID: 11236809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enantiomer-enantiomer interaction of ifosfamide in the rat.
    Lu H; Wang JJ; Chan KK
    Xenobiotica; 2006 Jun; 36(6):535-49. PubMed ID: 16865821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies.
    Tran HT; Madden T; Petropoulos D; Worth LL; Felix EA; Sprigg-Saenz HA; Choroszy M; Danielson M; Przepiorka D; Chan KW
    Bone Marrow Transplant; 2000 Sep; 26(5):463-70. PubMed ID: 11019834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M; Kuśnierczyk H; Budzyński W; Rak J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):275-84. PubMed ID: 3592931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers.
    Ducharme MP; Bernstein ML; Granvil CP; Gehrcke B; Wainer IW
    Cancer Chemother Pharmacol; 1997; 40(6):531-3. PubMed ID: 9332469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.
    Gex-Fabry M; Rudaz S; Balant-Gorgia AE; Brachet A; Veuthey JL; Balant LP; Bertschy G
    Eur J Clin Pharmacol; 2002 Aug; 58(5):323-31. PubMed ID: 12185556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model.
    Wainer IW; Granvil CP; Wang T; Batist G
    Cancer Res; 1994 Aug; 54(16):4393-7. PubMed ID: 8044787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide.
    Mace JR; Keohan ML; Bernardy H; Junge K; Niebch G; Romeis P; Thoma A; Wagner T; Mueller U; Demetri G; Baker LH
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5829-34. PubMed ID: 14676103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enantiospecific disposition of pranoprofen in beagle dogs and rats.
    Imai T; Nomura T; Aso M; Otagiri M
    Chirality; 2003 May; 15(4):312-7. PubMed ID: 12666237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic modelling of ifosfamide administered by continuous infusion on 5 days at the dose of 6 g/m2.
    Passe P; Delepine N; Arnaud P; Urien S; Delepine G; Traoré F; Desbois JC; Brion F
    Anticancer Res; 1999; 19(1B):837-42. PubMed ID: 10216502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of clinafloxacin enantiomers in humans.
    Humphrey GH; Shapiro MA; Randinitis EJ; Guttendorf RJ; Brodfuehrer JI
    J Clin Pharmacol; 1999 Nov; 39(11):1143-50. PubMed ID: 10579144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.